1. Home
  2. RLMD vs NISN Comparison

RLMD vs NISN Comparison

Compare RLMD & NISN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • NISN
  • Stock Information
  • Founded
  • RLMD 2004
  • NISN 2005
  • Country
  • RLMD United States
  • NISN China
  • Employees
  • RLMD N/A
  • NISN N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • NISN Metal Fabrications
  • Sector
  • RLMD Health Care
  • NISN Industrials
  • Exchange
  • RLMD Nasdaq
  • NISN Nasdaq
  • Market Cap
  • RLMD 20.3M
  • NISN 19.6M
  • IPO Year
  • RLMD N/A
  • NISN 2016
  • Fundamental
  • Price
  • RLMD $0.64
  • NISN $4.15
  • Analyst Decision
  • RLMD Buy
  • NISN
  • Analyst Count
  • RLMD 3
  • NISN 0
  • Target Price
  • RLMD $5.00
  • NISN N/A
  • AVG Volume (30 Days)
  • RLMD 211.8K
  • NISN 36.9K
  • Earning Date
  • RLMD 08-11-2025
  • NISN 04-29-2025
  • Dividend Yield
  • RLMD N/A
  • NISN N/A
  • EPS Growth
  • RLMD N/A
  • NISN N/A
  • EPS
  • RLMD N/A
  • NISN 1.43
  • Revenue
  • RLMD N/A
  • NISN $340,219,546.00
  • Revenue This Year
  • RLMD N/A
  • NISN N/A
  • Revenue Next Year
  • RLMD N/A
  • NISN N/A
  • P/E Ratio
  • RLMD N/A
  • NISN $17.90
  • Revenue Growth
  • RLMD N/A
  • NISN 8.05
  • 52 Week Low
  • RLMD $0.24
  • NISN $3.22
  • 52 Week High
  • RLMD $4.02
  • NISN $22.55
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 50.91
  • NISN 50.42
  • Support Level
  • RLMD $0.60
  • NISN $4.20
  • Resistance Level
  • RLMD $0.74
  • NISN $4.90
  • Average True Range (ATR)
  • RLMD 0.06
  • NISN 0.35
  • MACD
  • RLMD 0.00
  • NISN 0.03
  • Stochastic Oscillator
  • RLMD 44.19
  • NISN 45.65

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About NISN NiSun International Enterprise Development Group Co. Ltd.

NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.

Share on Social Networks: